Related by context. All words. (Click for frequent words.) 67 Therapy HAART 67 anti retroviral therapies 65 active antiretroviral therapy 63 Active Anti Retroviral 61 HAART regimen 60 pharmacokinetic interactions 60 relapsed MM 60 Antiretroviral therapy 60 anti tubercular 59 nucleoside analogues 59 chemotherapeutic regimens 59 HAART 59 Protease inhibitors 59 immune suppressive 58 ritonavir boosted protease inhibitor 58 Latent TB 58 Bcr Abl mutations 58 antiretroviral ARV therapy 58 Rifampicin 58 trastuzumab Herceptin ® 58 Anti retroviral 58 GRNOPC1 cells 57 potent antiretroviral therapy 57 Gag polymorphisms 57 resistant TB 57 Highly Active Antiretroviral 57 combination antiretroviral therapy 57 immunodeficient 57 antiretroviral medications 57 latent tuberculosis TB 57 antiretroviral therapies 57 multidrug resistant TB MDR 57 zidovudine AZT 57 nonnucleoside reverse transcriptase inhibitors 57 immunosuppressive regimens 57 multidrug 57 protease inhibitors PIs 56 PREZISTA rtv 56 intravenous bisphosphonates 56 resistant microorganisms 56 acid suppressive medications 56 beta lactam antibiotic 56 HAART regimens 56 anti retroviral therapy 56 efavirenz Sustiva 56 cisplatin chemotherapy 56 protease inhibitor PI 56 TMP SMX 56 therapeutic regimens 56 boosted protease inhibitor 56 recurrent glioblastoma multiforme 56 fluoroquinolone resistance 56 pyrimethamine 56 artemesinin 55 cART 55 immunosuppressive therapies 55 immunosuppressed patients 55 APTIVUS ritonavir 55 Valcyte 55 potent topically 55 Topical corticosteroids 55 Candida infection 55 Radical prostatectomy 55 lipid lowering therapy 55 pyrazinamide 55 postexposure prophylaxis 55 CellCept mycophenolate mofetil 55 Antiretroviral Therapy ART 55 basal cell nevus syndrome 55 nevirapine Viramune 55 cSSSIs 55 artemisinin derivative 55 PKC enzyme 55 latent tuberculosis infection 55 lenalidomide dexamethasone 55 MMP inhibitors 55 IFN beta 55 Isentress raltegravir 55 HBV infection 55 antituberculosis 55 antiretroviral therapy ART 55 Pneumocystis carinii pneumonia 55 Lofexidine 55 lipid lowering therapies 55 Nonalcoholic fatty liver 55 poliovirus vaccine 54 immunosuppressant therapy 54 nucleoside analogue 54 intensive lipid lowering 54 gemifloxacin 54 Gleevec resistant 54 infliximab Remicade 54 somatostatin analogs 54 immune modulating 54 Therapeutic hypothermia 54 antiandrogens 54 genital herpes infections 54 maximally tolerated lipid lowering 54 CsA 54 Liver transplantation 54 taxane chemotherapy 54 Gatifloxacin 54 idarubicin 54 stavudine d4T 54 lenalidomide Revlimid R 54 iron chelation 54 GnRH agonists 54 nucleoside analogs 54 PREZISTA r 54 antifungal medications 54 Herbal medicines 54 NNRTIs 54 candidemia 54 Antiretroviral treatment 54 differentiated thyroid 54 CMV disease 54 drugs tenofovir lamivudine 54 macrolide antibiotic 54 noscapine 54 immunocompetent 54 tamoxifen Nolvadex ® 54 potassium sparing diuretics 54 CRBSIs 54 inhaled glucocorticoids 54 antihypertensive therapy 54 vaginal microbicides 54 artemisinins 54 Pneumococcal vaccines 54 carbapenem antibiotics 54 antiretroviral therapy 54 Calorie restriction 54 Edurant 54 antiretroviral regimen 54 receiving PREZISTA r 54 resistant XDR 54 vitamin D analogs 54 tigecycline 54 Combination therapy 53 antiretroviral regimens 53 direct thrombin inhibitors 53 nonpharmacologic 53 lipid lowering medications 53 anticipated pill Acomplia 53 co trimoxazole 53 antiretroviral naive 53 HIV HCV coinfected 53 myeloablative 53 interferon IFN 53 S. aureus infection 53 Gilead Viread 53 TB bacilli 53 nephrotoxic drugs 53 diabetic kidney 53 radioiodine therapy 53 chlamydial infection 53 Anti retroviral therapy 53 conserved sequences 53 statins cholesterol lowering 53 iPrEx study 53 ß blockers 53 Kivexa 53 immunosuppressive medications 53 Epstein Barr virus EBV 53 TKI therapy 53 Antiretroviral drugs 53 inhibit replication 53 anti retroviral treatments 53 undruggable targets 53 vWD 53 GRNOPC1 contains 53 Amodiaquine 53 methotrexate therapy 53 HCV protease inhibitors 53 recurrent genital herpes 53 potent cytotoxic 53 Opportunistic infections 53 paricalcitol 53 valganciclovir 53 opioid dependent 53 biologic DMARDs 53 hematological malignancy 53 P. falciparum malaria 53 triple nucleoside regimen 53 MDR tuberculosis 53 statin medications 53 staphylococcal infections 53 Androgen deprivation therapy 53 curative therapies 53 standard chemotherapy regimens 53 Chlamydia trachomatis infection 53 Cabazitaxel 53 nonvaccine 53 multidrug resistant strains 53 Adjuvant chemotherapy 53 adalimumab Humira 53 rituximab Rituxan 53 DHEA supplements 53 vinca alkaloid 53 tuberculin skin testing 53 Plasmodium falciparum malaria 53 hormonal therapies 53 therapies ACTs 53 immune suppressive drugs 53 pharmacologic intervention 53 Valproic acid 53 chronic HCV infection 53 EBV infection 53 Zevalin consolidation 53 herpes zoster shingles 53 chemo radiotherapy 53 hepatotoxic 53 CHOP chemotherapy 53 latent infection 53 refractory Hodgkin 53 corticosteroid therapy 53 microtubule inhibitor 53 anti retroviral medications 53 Rilonacept 53 immuno suppressive 53 curable cancers 53 cytoreduction 53 erlotinib Tarceva ® 53 AZT zidovudine 53 purified inactivated vaccine 53 LCMV infection 53 pharmacotherapeutic 53 antiviral therapy 53 Methicillin 53 Crucell rabies monoclonal antibody 53 NRTI backbone 53 NNRTI resistance 53 Fuzeon enfuvirtide 52 uric acid lowering 52 TDF FTC 52 TB MDR TB 52 Photodynamic therapy PDT 52 chronic GVHD 52 virologic suppression 52 resistant organisms 52 ovulatory cycles 52 analgesic medications 52 indinavir 52 3TC lamivudine Epivir 52 antigen sparing 52 dosing frequency 52 RAS blockers 52 EXJADE 52 multidrug resistant 52 cytotoxic chemotherapy 52 Valcyte tablets 52 invasive candidiasis 52 Cytoxan 52 LHRH agonist 52 Surgical excision 52 thalidomide Thalomid 52 MDS AML 52 cytomegalovirus CMV 52 CCR5 receptor antagonist 52 resistant XDR TB 52 transgenic rats 52 NRTIs 52 DFMO 52 antiviral prophylaxis 52 interferon ribavirin 52 Glivec imatinib 52 Respiratory syncytial virus RSV 52 empiric therapy 52 chemoprophylaxis 52 antiretroviral ARV medication 52 chlamydial 52 myopathy rhabdomyolysis 52 antiangiogenic agents 52 cytomegalovirus retinitis 52 CD4 + cells 52 hepatitis C HCV 52 nucleoside analog 52 Falciparum malaria 52 HMG CoA reductase inhibitory 52 N acetylcysteine 52 Inhaled corticosteroids 52 Hormonal therapy 52 HCV antibody 52 symptomatic hyponatremia 52 ano genital warts 52 emtricitabine FTC 52 hepatorenal syndrome 52 beta blockers ACE inhibitors 52 calcineurin inhibitors 52 antiangiogenic therapy 52 anti TNFs 52 Anti retroviral drugs 52 progressive PsA 52 neuroendocrine cancers 52 nephrotoxicity 52 suppressive therapy 52 VZV 52 antiplatelet therapies 52 alkylating agents 52 Naive Patients 52 neutrophil counts 52 inotropes 52 imipenem 52 aspirin clopidogrel 52 serum HBV DNA 52 immune suppressing 52 UDCA 52 biomarker identification 52 immunomodulatory therapy 52 Glioblastoma multiforme GBM 52 antimicrobial prophylaxis 52 lipid lowering medication 52 toxoid 52 beta lactam antibiotics 52 dapsone 52 d4T stavudine Zerit 52 SIV infected 52 biphosphonates 52 HIV coinfected 52 thromboembolic disease 52 ganciclovir 52 genotypic resistance 52 pemphigus vulgaris 52 reverse transcriptase inhibitors 52 BEXXAR Therapeutic Regimen 52 antiviral regimens 52 ritonavir boosted PI 52 insomnia sufferers 52 LHRH analogues 52 coinfected patients 52 pegfilgrastim 52 Aspergillus infections 52 nucleoside reverse transcriptase inhibitors 52 mycophenolate mofetil 52 antirheumatic 52 anagrelide 52 immune modulator 52 ritonavir boosted 52 β blocker 52 tipranavir ritonavir 52 Genital HPV 52 opiate dependence 52 NNRTI 52 HCV infected 52 cytotoxic agents 52 paclitaxel Taxol 52 cytarabine daunorubicin 52 prospective Courville 52 immunomodulatory 52 allogeneic HSCT 52 artemisinin combination 52 aldosterone antagonists 52 molecularly targeted therapies 52 prospective Quesnel Trough 52 lupus nephritis 51 mitochondrial toxicity 51 letrozole Femara 51 ethambutol 51 pimozide 51 S. aureus isolates 51 antiinflammatory drugs 51 injectable contraceptives 51 tricyclic antidepressant 51 Vaginal gel 51 immunosuppression 51 ritonavir boosted lopinavir 51 chemotherapy regimens 51 postexposure 51 transcriptase inhibitors 51 Adenoviruses usually cause 51 unprotected vaginal 51 overlapping toxicities 51 pegylated alpha interferon 51 mycophenolate 51 Herbal remedies 51 APTIVUS r 51 drugs isoniazid 51 N. gonorrhoeae 51 lopinavir ritonavir Kaletra 51 HCV infections 51 virotherapy 51 Artemisinin Combination Therapies ACTs 51 interferon beta therapy 51 cefuroxime 51 rifapentine 51 Raltegravir 51 radiolabeled TM# 51 CCR5 inhibitor 51 imatinib Gleevec 51 hydroxychloroquine 51 HbF 51 Natalizumab 51 acid suppressing 51 prevalent sexually transmitted 51 AZT zidovudine Retrovir 51 elevated triglyceride levels 51 smoldering multiple myeloma 51 viremia 51 bronchodilator therapy 51 inhaled bronchodilators 51 CMV infections 51 Protease inhibitor 51 latent TB infection 51 MabThera Rituxan 51 prednisone prednisolone 51 Genital herpes 51 Sexually Transmitted Infections STI 51 herpes infections 51 nifurtimox 51 GIST tumors 51 unprotected receptive anal 51 H. pylori eradication 51 chemoresistant 51 antiangiogenic 51 Cholesterol lowering statins 51 antiepileptic drugs AEDs 51 P. vivax malaria 51 multimodal analgesia 51 nucleotide analogue 51 buprenorphine naloxone 51 induce remission 51 saquinavir ritonavir 51 Anti malarial 51 relapsed ALL 51 TNF antagonist 51 polytherapy 51 plus prednisone prednisolone 51 LHRH agonists 51 immunosuppressives 51 anti androgen 51 Blinatumomab 51 Mitomycin C 51 alefacept 51 hepatitis C genotype 51 parenterally administered 51 bezafibrate 51 antiandrogen 51 pharmacological therapies 51 decompensated liver disease 51 smoking cessation therapies 51 heavily pretreated 51 BEXXAR therapeutic regimen 51 Lipitor #mg 51 nonmelanoma skin cancers 51 antiangiogenesis 51 NUCYNTA R 51 anti angiogenic agents 51 DMARDS 51 dyslipidemias 51 C. trachomatis 51 electrical cardioversion 51 Cloretazine 51 fulvestrant 51 Sustiva efavirenz 51 neurotrophic 51 sulfadoxine pyrimethamine 51 Oral corticosteroids 51 Helicobacter pylori H. pylori 51 liver metastasis 51 beta agonists 51 renoprotective 51 lipid lowering drugs 51 herpes zoster vaccine 51 Kidney transplantation 51 antitumoral 51 hematologic toxicity 51 viremic 51 KETEK 51 atazanavir Reyataz 51 Bone marrow transplantation 51 drug DMARD 51 Minimally invasive procedures 51 cardiotoxic 51 androgen therapy 51 antiplatelet medications 51 Pertuzumab 51 antiretroviral treatments 51 opiate dependency 51 RDTs 51 mercaptopurine 51 amisulpride 51 elvitegravir 51 investigational integrase inhibitor 51 inhaled budesonide 51 multidrug resistant tuberculosis MDR 51 nonhormonal 51 multidrug resistant MDR 51 hepatic fibrosis 51 BRAF mutation 51 HAV infection 51 neutropenic patients 51 empiric treatment 51 oral antidiabetes drugs 51 ursodeoxycholic acid 51 interferon sparing 51 pathogenic viruses 51 loop diuretic 51 colorectal liver metastases 51 alkylating 51 Heterosexual transmission 51 serotype #A 51 Atypical antipsychotics 51 serum lipid levels 51 SCIg 51 Velcade bortezomib 51 leukotriene receptor antagonist 51 Renal impairment 51 radiosensitive 51 acid suppressive drugs 51 caspofungin 51 gonococcal infections 51 ovulation inducing 51 Multi Drug Resistant 51 antifungal compounds 51 raloxifene Evista 51 antiviral therapies 51 BRCA mutation carriers 51 SIV infection 51 receptor inhibitor 51 virtually untreatable 51 serum creatinine levels 51 isoniazid 51 CD4s 51 virologically suppressed 51 Cytolin R 51 pharmacologically active isomer 51 bacterial sexually transmitted 51 gatifloxacin 51 Abacavir 51 lopinavir 51 transgene expression 51 postmenopausal hormone 51 ARV therapy 51 cirrhotic 51 Pegasys peginterferon alfa 2a 51 fibrinolytic 51 Cisplatin 51 cancerdefine 51 mda 7 51 immunosuppressive agents 51 MYCAMINE 51 pegylated interferon alfa 51 chronic HBV 51 intra abdominal infections 50 panobinostat 50 convenient dosing regimens 50 HIV infection 50 relapsed ovarian cancer 50 multidrug resistance 50 selenium supplementation 50 coinfection 50 sero positive 50 Anti depressant 50 β blockers 50 adrenal suppression 50 superinfection 50 Combivir Kivexa 50 tenofovir Viread 50 androgen deficiency 50 antiretroviral naïve 50 cotrimoxazole prophylaxis 50 intranasal corticosteroids 50 immunosuppressive drugs 50 Nilotinib 50 cidofovir 50 pharmacologic stress 50 HBV vaccine 50 ziconotide 50 virological failure 50 genital ulcer 50 Circumcised men 50 gastrointestinal absorption 50 proliferative disorders 50 ddI 50 immuno compromised individuals 50 invasive fungal infections 50 immuno compromised patients 50 pharmacologic treatments 50 vasodilators 50 abacavir lamivudine 50 prostate cancer CaP 50 oral poliovirus 50 atypical antipsychotic medications 50 intravenous iv 50 superficial bladder cancer 50 immunosuppressed 50 erlotinib Tarceva 50 mycophenolate mofetil MMF 50 antitumour 50 Tenofovir DF 50 fosamprenavir 50 canakinumab 50 psoralen 50 mild gestational diabetes 50 recombinant erythropoietin 50 testosterone supplementation 50 antithrombotics 50 nucleoside reverse transcriptase inhibitor 50 cytostatic 50 newer atypical antipsychotic 50 chemopreventive agents 50 metastatic kidney 50 dose cyclophosphamide 50 Thiovir 50 efavirenz emtricitabine 50 sodium stibogluconate 50 opioid substitution 50 immuno therapy 50 HBeAg negative 50 latently infected 50 curative therapy 50 ALDH2 50 Waldenstrom macroglobulinemia 50 Membrane proteins 50 drug resistant XDR 50 psychopharmacologic 50 Hepatocellular carcinoma HCC 50 vivax 50 loop diuretics 50 Pemetrexed 50 Psychosocial interventions 50 immuno suppressed 50 receiving TEMODAR 50 pegylated liposomal doxorubicin 50 abacavir sulfate 50 disease modifying antirheumatic 50 echinocandin 50 pharmacological intervention 50 thiazide diuretic 50 metastatic RCC 50 suppress viral replication 50 malarial parasites 50 antiinflammatory 50 postoperative AF 50 genital ulcers 50 DMARD therapy 50 immunomodulating 50 metastatic lymph nodes 50 Pegylated Interferon 50 antibody mediated rejection 50 dasatinib Sprycel 50 subtherapeutic 50 ribavirin therapy 50 Telmisartan 50 cilengitide 50 Anopheles gambiae mosquitoes 50 immune globulins 50 Stat5 50 undetectable viral loads 50 Multidrug resistant 50 neovascular diseases 50 metastatic renal cell carcinoma 50 SELZENTRY 50 non hodgkin lymphoma 50 Postherpetic neuralgia 50 malabsorptive 50 NNRTI resistant virus 50 slow progressors 50 echinocandins 50 plant Artemisia annua 50 falciparum malaria 50 Epivir 50 Platinol ® cisplatin 50 Highly Active 50 Tekamlo 50 intra arterial chemotherapy 50 placebo dexamethasone 50 proguanil 50 rosuvastatin Crestor 50 Antiretroviral ARV 50 Malignant glioma 50 resistant superbugs 50 rifampicin 50 protease inhibitors 50 TNF alpha antagonist 50 ART regimens 50 intravenous cyclophosphamide 50 receptive anal intercourse 50 Artesunate 50 serum phosphate 50 anticonvulsants 50 nonadherent 50 relapsed leukemia 50 nelfinavir 50 basal cell cancers 50 primaquine 50 topical retinoids 50 tipranavir 50 photosensitiser 50 dose ritonavir 50 communicable chronic 50 Surgical resection 50 doxorubicin Adriamycin 50 riociguat 50 TechTeam fertilizers 50 traumatic disabling neurological 50 mTOR inhibitors 50 acute respiratory tract infections 50 HCV antibodies 50 active PsA 50 virologically 50 Homeopathic medicines 50 Selzentry maraviroc 50 ZYVOX 50 Cotrimoxazole 50 hormone deprivation 50 seropositive 50 OHR/AVR# 50 sulfamethoxazole 50 recombinant interferon 50 bacillus Calmette Guerin 50 MULTAQ 50 CMV infection 50 immunocompromised patients 50 CMV retinitis 50 progressive psoriatic arthritis 50 neoadjuvant therapy 50 TB germ 50 Photodynamic therapy 50 oral anticoagulants 50 non resectable liver 50 antithrombotic therapy 50 chemotherapeutic regimen 50 Chloroquine 50 Klyuchevskaya Sopka Eurasia 50 APTIVUS 50 Antiviral drugs 50 etravirine 50 monotherapies 50 duodenal ulcer 50 Tetrodotoxin 50 MRSA vancomycin 49 herpetic keratitis 49 biologic DMARD 49 griseofulvin 49 FUSILEV enhances 49 regorafenib 49 Pap smear screening 49 Sexually transmitted infections STIs 49 polioviruses 49 iron chelators 49 trimethoprim sulfamethoxazole 49 methylene blue 49 alkylating agent 49 posterior uveitis 49 anti retroviral medication 49 EGFR tyrosine kinase inhibitors 49 Rimantadine 49 antidepression 49 antianginal 49 hormonal treatments 49 Japanese Encephalitis virus 49 receiving antiretroviral therapy 49 RRMS patients 49 CCR5 antagonists 49 Viral load 49 polysaccharide vaccines 49 necrotizing pneumonia 49 antithrombotic 49 colorectal carcinogenesis 49 lamivudine 3TC 49 shooter Thweatt 49 liver transplant recipients 49 MAO inhibitors 49 asymptomatic hyperuricemia 49 peginterferon 49 asymptomatic carotid stenosis 49 ESBL producing E. coli 49 Hepatitis C infections 49 Diamyd r 49 metastatic lung cancer 49 rFVIIa 49 prospective observational studies 49 Trichomonas vaginalis 49 immunosuppressive molecule 49 lichen planus 49 antihypertensive drugs 49 HIV protease inhibitors 49 enfuvirtide 49 CCR5 inhibitors 49 PTLD 49 leukoreduction 49 imexon 49 antifungal drugs 49 stavudine 49 grade cervical dysplasia 49 Crizotinib 49 Src inhibitors 49 Anti TNF 49 Topical treatments 49 paclitaxel cisplatin 49 lamivudine zidovudine 49 nanoviricide 49 pneumocystis pneumonia 49 pegylated IFN 49 aldosterone antagonist 49 GSTM1 gene 49 Mycophenolate mofetil 49 antihypertensive medication 49 Imatinib 49 Tindamax R 49 virology Progenics 49 Pneumococcal pneumonia 49 glitazone 49 Herceptin trastuzumab 49 PegIFN RBV 49 systemic corticosteroid 49 Triptans 49 droperidol 49 rituximab Rituxan ® 49 immune reconstitution syndrome 49 pyridostigmine 49 Corticosteroids 49 endometrial carcinoma 49 COPD exacerbations 49 antipsychotic prescribing 49 Influenza vaccination 49 transfusion transmitted 49 paroxetine Paxil 49 MTP inhibitors 49 certolizumab 49 NRTI resistance 49 relapsing remitting MS RRMS 49 Alemtuzumab 49 antibiotic streptomycin 49 abacavir containing 49 Sentinel node biopsy 49 antiretroviral ARV 49 cytoprotective 49 resistant superbug 49 lapatinib Tykerb 49 Saquinavir 49 cotrimoxazole 49 serum urate levels 49 ALT flares 49 HIV seropositive 49 atypical neuroleptics 49 anticholinergic medications 49 imatinib resistance 49 antioxidant supplementation 49 HIV seroconversion 49 anticancer therapies 49 bevacizumab Avastin 49 metastatic malignant melanoma 49 antiarrhythmic drug 49 Smallpox vaccine 49 noninfectious uveitis 49 antiresorptive 49 lipid lowering agents 49 lung metastasis 49 precancerous cervical lesions 49 genital HPV infections 49 commercializes implantable 49 antiemetics 49 immunosuppressive regimen 49 tenofovir emtricitabine 49 rifabutin 49 visilizumab 49 taxane therapy 49 phosphodiesterase inhibitors 49 Alpha lipoic acid 49 Gleevec imatinib 49 caustic byproduct 49 adenovirus infections 49 sustained virological response 49 acute GVHD 49 vaginal microbicide gel 49 dexamethasone Decadron 49 nonpharmacological 49 Ebola Hemorrhagic Fever 49 postoperative infections 49 Non Hodgkins lymphoma 49 bacillus Calmette Guerin BCG 49 taxotere 49 mutant KRAS 49 Reverset 49 ROTARIX 49 Retreatment 49 colorectal tumors 49 motile cells 49 docetaxel Taxotere 49 serum calcium levels 49 abacavir Ziagen 49 inhibit platelet function 49 purified omega 49 injectable polio vaccine 49 antifungal therapy 49 triglyceride lowering 49 nonpregnant adults 49 immunosuppressant drug 49 low dose ritonavir 49 adefovir dipivoxil 49 monovalent oral polio vaccine 49 neuroleptics 49 external beam radiotherapy 49 Antiretrovirals 49 urate levels 49 HPV genotypes 49 cyproterone acetate 49 endocrine therapies 49 Cryptococcus neoformans 49 waterborne microbes 49 Circumcision reduces 49 K#N 49 cholinesterase inhibitor 49 folinic acid 49 decitabine 49 EGFRIs 49 intensive statin therapy 49 metastatic renal cell 49 bacteriostatic properties 49 combination therapies ACTs 49 P. falciparum parasites 49 eculizumab therapy 49 anti cholinesterase 49 interferon injections 49 vector mosquitoes 49 immune suppressants 49 CCR5 antagonist 49 Viread tenofovir disoproxil fumarate 49 venous blood clots 49 resistant pathogens 49 cIAI 49 galiximab 49 blood clot dissolving 49 dengue haemorrhagic fever DHF 49 lymphocyte counts 49 severely immunocompromised 49 Pseudomonas aeruginosa infections 49 non pharmacological interventions 49 vasopressors 49 poor metabolizers 49 triple nucleoside 49 DMARD 49 paclitaxel Taxol ® 49 multidrug resistant MDR TB 49 Tipranavir 49 AA Amyloidosis 49 multitargeted 49 MGUS 49 carbapenem 49 NMDA antagonists 49 H2 receptor antagonists 49 systemic immunosuppressive 49 antiretrovirals 49 pre exposure prophylaxis 49 hepatitis C virus 49 cranial irradiation 49 gastrointestinal stromal tumors GIST 49 Mitoxantrone 49 Inert ingredients 49 antibiotic ceftriaxone 49 viral loads 49 chemotherapy radiotherapy 49 multidrug resistant organisms 49 hepatitis B infection 49 HIB vaccine 49 Glioblastoma Multiforme 49 Invasive pneumococcal disease 49 topical NSAIDs 49 Subgroup analyzes 49 mycobacterial infections 49 T1DM 49 anti secretory 49 WNV infections 49 postoperative pulmonary 49 A1c levels 49 serum PTH 49 ACE inhibitor lisinopril 49 Chlamydia infections 49 inactivated influenza vaccines 49 opiate analgesics 49 telomerase activation 49 Serum calcium 49 immunomodulatory properties 49 d4T 49 smallpox SIGA 49 Acute myeloid leukemia 49 virus RSV 49 cryptococcal meningitis 49 antiretroviral medication 49 Adjuvant therapy 49 diuretic hydrochlorothiazide 49 Acinetobacter infections 49 thymic carcinoma 49 dietary phosphate 49 Novartis Gleevec 48 maximal doses 48 AF ablation procedures 48 Darunavir 48 inotropic 48 long acting bronchodilator 48 irinotecan chemotherapy 48 refractory SCLC 48 pegylated interferons 48 telomere lengths 48 nosocomial infection 48 Muscle relaxants 48 Valopicitabine 48 Paraplatin ® carboplatin